Citations (5)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Akhil Rajendra, Manju Sengar, V.N. Avinash Bonda, Hasmukh Jain, Lingaraj Nayak, Jayashree Thorat, Tanuja Shet, Sridhar Epari, Siddharth Laskar, Archi Aggarwal, V. Rangarajan, Sumeet Gujral, Bhausaheb Bagal, Sangeeta Kakoti & Omkar Salvi. (2023) Outcomes and prognostic factors of patients with Extranodal NK T cell lymphoma (ENKTL). Leukemia & Lymphoma 64:12, pages 1914-1926.
Read now
Read now
Articles from other publishers (4)
Yu-Ce Wei, Wei-Xin Liu, Fei Qi, Chang-Gong Zhang, Bao-Min Zheng, Yan Xie, Bo Chen, Di Zhang, Wei-Ping Liu, Hui Fang, Yue Chai, Shu-Nan Qi, Ye-Xiong Li, Wei-Hu Wang, Yu-Qin Song, Jun Zhu & Mei Dong. (2023) Clinical features, prognostic stratification, and treatment of advanced-stage non-nasal type extranodal natural killer/T-cell lymphoma: a multi-institutional real-world study. Annals of Hematology 103:1, pages 163-174.
Crossref
Crossref
Bradley Haverkos, Onder Alpdogan, Robert Baiocchi, Jonathan E. Brammer, Tatyana A. Feldman, Marcelo Capra, Elizabeth A. Brem, Santosh Nair, Phillip Scheinberg, Juliana Pereira, Leyla Shune, Erel Joffe, Patricia Young, Susan Spruill, Afton Katkov, Robert McRae, Ivor Royston, Douglas V. Faller, Lisa Rojkjaer & Pierluigi Porcu. (2023) Targeted therapy with nanatinostat and valganciclovir in recurrent EBV-positive lymphoid malignancies: a phase 1b/2 study. Blood Advances 7:20, pages 6339-6350.
Crossref
Crossref
Zheng Yan, Shuna Yao, Zhizhong Wang, Wenping Zhou, Zhihua Yao & Yanyan Liu. (2023) Treatment of extranodal NK/T-cell lymphoma: From past to future. Frontiers in Immunology 14.
Crossref
Crossref
Yang Chunli, Jiang Ming, Ma Ziyan, Ji Jie, Lv Shuli, Huang Jie, Wu Yu, Xu Caigang & Zou Liqun. (2022)
Real‐World
clinical features and survival outcomes associated with primary gastrointestinal natural killer/T‐cell lymphoma from 1999 to 2020
. Cancer Medicine 12:3, pages 2614-2623.
Crossref
Crossref